Transepithelial corneal crosslinking in treatment of progressive keratoconus: 12 months' clinical results
Pakistan Journal of Medical Sciences. 2017; 33 (3): 570-575
em Inglês
| IMEMR
| ID: emr-188029
ABSTRACT
Objective:
The purpose of this study was to evaluate the safety and efficacy of transepithelial corneal collagen cross linking [TE-CXL] with modified riboflavin and accelerated UVA irradiance in thin corneas with pachymetry less than 400 microns at thinnest point, untreatable by epithelium off corneal collagen cross linking[CXL] in adult Pakistani population with progressive keratoconus
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Pak. J. Med. Sci.
Ano de publicação:
2017
Similares
MEDLINE
...
LILACS
LIS